AB0169 Early remission at 6 months as a predictor of longterm remission in new onset rheumatoid arthritis
(2022) EULAR 2022 European Congress of Rheumatology — Location: (Denmark) Copenhagen (1.June.2022)
Files
1214full.pdf
Open Access - Adobe PDF
- 256.38 KB
Details
- Authors
- Abstract
- (en) BACKGROUND Early therapeutic intervention is crucial for patients with early rheumatoid arthritis (ERA). The goal of remission is achievable in a large proportion of ERA patients. OBJECTIVES To evaluate the rate of patients in remission at 6 months and to correlate the 36 and 60 months remission rate in the Belgian CAP48 cohort and the UCLouvain Brussels cohort. To identify baseline characteristics differences between patients achieving remission or not. METHODS We included patients with ERA from the CAP48 cohort and from the UCLouvain Brussels cohort who met the ACR/EULAR 2010 RA classification criteria. All patients were naïve to csDMARDs therapy. We collected patient characteristics at baseline and clinical response was analysed at 6, 36 and 60 months. RESULTS 287 RA patients from our UCLouvain Brussels Cohort and the CAP48 cohort were analysed (211 Females, 76 Males, mean age 46.2 years, 43.4% with baseline erosion, 70.1% with ACPA, 70.3% with Rheumatoid Factor, mean HAQ 1.16, mean DAS28-CRP 4.67, mean SDAI 24.9 and mean CDAI 24.1). […]
- Affiliations
Citations
Sapart, E., Sokolova, T., Avramovska, A., Sidiras, P., Kleimberg, S., Dierckx, S., Meric de Bellefon, L., Ribbens, C., Malaise, M., Di Romana, S., Badot, V., & Durez, P. (2022). AB0169 Early remission at 6 months as a predictor of longterm remission in new onset rheumatoid arthritis. Annals of the rheumatic diseases, 81(Suppl 1), 1214. https://doi.org/10.1136/annrheumdis-2022-eular.1949 (Original work published 2022)